Clinical Trial Update: Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the Cardioblate Closure Device for left atrial appendage occlusion was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Cardioblate Closure Device

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Left Atrial Appendage Occlusion | Phase 2 | Status: TERMINATED